Maxcyte Inc (MXCT)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt MXCT? Forum Prognose

Finanzdaten der Maxcyte Inc-Aktie (MXCT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	19.72% 6.829	8.507	10.39	8.693	8.164
Cost Of Revenue	5.07% 1.596	1.519	1.497	2.281	1.928
Gross Profit	25.11% 5.233	6.988	8.893	6.412	6.236
Operating Expenses	8.64% 19.38	21.21	21.19	19.31	20.29
Benefits Costs and Expenses	7.76% 19.25	20.86	20.65	19.29	19.72
Costs And Expenses	7.76% 19.25	20.86	20.65	19.29	19.72
Depreciation and Amortization	3.33% 1.044	1.08	1.061	1.02	1.021
Operating Income/Loss	0.55% -14.15	-14.23	-12.29	-12.90	-14.05
Income/Loss From Continuing Operations Before Tax	0.48% -12.42	-12.36	-10.26	-10.60	-11.56
Income/Loss From Continuing Operations After Tax	0.48% -12.42	-12.36	-10.26	-10.60	-11.56
Net Income/Loss	0.48% -12.42	-12.36	-10.26	-10.60	-11.56
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.20% 106.61	106.40	105.95	0.2345	105.11
Diluted Average Shares	0.20% 106.61	106.40	105.95	0.2345	105.11
Basic Earnings Per Share	0.00% -0.12	-0.12	-0.10	-0.10	-0.11
Diluted Earnings Per Share	0.00% -0.12	-0.12	-0.09	-0.10	-0.11
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ZBH

$93.20

0.66%

STE

$214.57

1.05%

DXCM

$64.24

1.56%

PHG

$27.79

1.66%

GEHC

$70.77

0.63%

$81.81

3.31%